IDEAYA Biosciences (IDYA) Misses Q2 EPS by 9c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q2 EPS of ($0.88), $0.09 worse than the analyst estimate of ($0.79).

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• UBS Downgrades Core Natural Resources (CNR) to Neutral
• Goldman Sachs Reiterates Buy Rating on Rubrik Inc (RBRK)
• JPMorgan Downgrades Reliance Worldwide Corp Ltd (RWC:AU) (RLLWF) to Neutral